585 related articles for article (PubMed ID: 32629534)
1. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
[TBL] [Abstract][Full Text] [Related]
2. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
[TBL] [Abstract][Full Text] [Related]
3. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
[TBL] [Abstract][Full Text] [Related]
4. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
[TBL] [Abstract][Full Text] [Related]
5. The Ehlers-Danlos syndromes, rare types.
Brady AF; Demirdas S; Fournel-Gigleux S; Ghali N; Giunta C; Kapferer-Seebacher I; Kosho T; Mendoza-Londono R; Pope MF; Rohrbach M; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Zschocke J; Malfait F
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):70-115. PubMed ID: 28306225
[TBL] [Abstract][Full Text] [Related]
6. The 2017 international classification of the Ehlers-Danlos syndromes.
Malfait F; Francomano C; Byers P; Belmont J; Berglund B; Black J; Bloom L; Bowen JM; Brady AF; Burrows NP; Castori M; Cohen H; Colombi M; Demirdas S; De Backer J; De Paepe A; Fournel-Gigleux S; Frank M; Ghali N; Giunta C; Grahame R; Hakim A; Jeunemaitre X; Johnson D; Juul-Kristensen B; Kapferer-Seebacher I; Kazkaz H; Kosho T; Lavallee ME; Levy H; Mendoza-Londono R; Pepin M; Pope FM; Reinstein E; Robert L; Rohrbach M; Sanders L; Sobey GJ; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Wheeldon N; Zschocke J; Tinkle B
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):8-26. PubMed ID: 28306229
[TBL] [Abstract][Full Text] [Related]
7. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
Micale L; Fusco C; Castori M
Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
[TBL] [Abstract][Full Text] [Related]
8. Ehlers-Danlos syndromes: importance of defining the type.
van Dijk FS; Ghali N; Chandratheva A
Pract Neurol; 2024 Mar; 24(2):90-97. PubMed ID: 38160052
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic outcomes for molecular genetic testing in children with suspected Ehlers-Danlos syndrome.
Damseh N; Dupuis L; O'Connor C; Oh RY; Wang YW; Stavropoulos DJ; Schwartz SB; Mendoza-Londono R
Am J Med Genet A; 2022 May; 188(5):1376-1383. PubMed ID: 35128800
[TBL] [Abstract][Full Text] [Related]
10. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
Martin A
Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
[TBL] [Abstract][Full Text] [Related]
11. Placing joint hypermobility in context: traits, disorders and syndromes.
Morlino S; Castori M
Br Med Bull; 2023 Sep; 147(1):90-107. PubMed ID: 37350130
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Shoulder and Knee Instability in Patients with Ehlers-Danlos Syndrome: Joint Hypermobility Syndrome.
Homere A; Bolia IK; Juhan T; Weber AE; Hatch GF
Clin Orthop Surg; 2020 Sep; 12(3):279-285. PubMed ID: 32904109
[TBL] [Abstract][Full Text] [Related]
13. Hypermobility, the Ehlers-Danlos syndromes and chronic pain.
Syx D; De Wandele I; Rombaut L; Malfait F
Clin Exp Rheumatol; 2017; 35 Suppl 107(5):116-122. PubMed ID: 28967365
[TBL] [Abstract][Full Text] [Related]
14. Molecular Genetics and Pathogenesis of Ehlers-Danlos Syndrome and Related Connective Tissue Disorders.
Ritelli M; Colombi M
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32414079
[TBL] [Abstract][Full Text] [Related]
15. [Up-to-date classification and multidisciplinary symptoms of Ehlers-Danlos syndromes].
Ralovich FV; Kiss N; Horváth K; Kárpáti S; Medvecz M
Orv Hetil; 2019 Apr; 160(16):603-612. PubMed ID: 30983397
[TBL] [Abstract][Full Text] [Related]
16. Contemporary approach to joint hypermobility and related disorders.
Castori M; Hakim A
Curr Opin Pediatr; 2017 Dec; 29(6):640-649. PubMed ID: 28906340
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
Chiarelli N; Zoppi N; Venturini M; Capitanio D; Gelfi C; Ritelli M; Colombi M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831458
[TBL] [Abstract][Full Text] [Related]
18. Young Italian clinician wins Opitz award: Winner details evidence that conditions involving hypermobility are one entity.
Am J Med Genet A; 2015 Oct; 167A(10):ix-x. PubMed ID: 26355289
[No Abstract] [Full Text] [Related]
19. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Yew KS; Kamps-Schmitt KA; Borge R
Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
